The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes.
Open accessAbstract
BACKGROUND: The aim of this study was to investigate the association of lipoprotein fractions with the future risk of coronary heart disease (CHD) in patients with non-insulin-dependent diabetes (NIDDM). METHODS AND RESULTS: At baseline, lipoprotein fractions were determined in 313 diabetic patients with NIDDM (153 men and 160 women), and these patients were followed up for 7 years with respect to CHD events (CHD death or all CHD events including CHD death or nonfatal myocardial infarction). Altogether, 56 NIDDM patients (28 men and 28 women) died from CHD and 25 had a nonfatal myocardial infarction (17 men and 8 women) during the follow-up. NIDDM patients having these CHD events during the follow-up had higher levels of total and very-low-density lipoprotein (VLDL) triglycerides and VLDL cholesterol and lower levels of high-density lipoprotein (HDL) and HDL2 cholesterol than those without CHD events. The risk for CHD death was fourfold and for all CHD events, twofold higher among diabetics with low HDL cholesterol (< 0.9 mmol/L) than among diabetics with HDL cholesterol > or = 0.9 mmol/L. High triglyceride level (> 2.3 mmol/L) was associated with a twofold increase in the risk of CHD events. In multiple logistic regression analyses, HDL was inversely associated with CHD events and VLDL triglycerides with CHD events in NIDDM patients with low HDL cholesterol level (< or = 1.12 mmol/L). CONCLUSIONS: Our 7-year follow-up study gives evidence that low HDL and HDL2 cholesterol, high VLDL cholesterol, and high total and VLDL triglycerides are powerful risk indicators for CHD events in patients with NIDDM:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Goodman, D. S. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380010040006 · Cited by 2,246
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
High-Density Lipoprotein — The Clinical Implications of Recent Studies
Desforges, J. F., Gordon, D. J., & Rifkind, B. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211907 · Cited by 1,547
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.
Tall, A. R. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114722 · Cited by 652
Lipoprotein metabolism in diabetes mellitus.
Howard, B. V. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38659-4 · Cited by 636
Miller, N. E. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90638-7 · Cited by 468
West, K. M., Ahuja, M. M. S., Bennett, P. H., Czyzyk, A., De Acosta, O. M., Fuller, J. H., Grab, B., Grabauskas, V., Jarrett, R. J., Kosaka, K., et al. (1983) · Diabetes Care · doi:10.2337/diacare.6.4.361 · Cited by 408
Patsch, J. R., Karlin, J. B., Scott, L. W., Smith, L. C., & Gotto, A. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1449 · Cited by 386
C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus
Faber, O. K., & Binder, C. (1977) · Diabetes · doi:10.2337/diab.26.7.605 · Cited by 386
Epidemiology of triglycerides: A view from Framingham
Castelli, W. P. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91083-g · Cited by 346
Laakso, M., Sarlund, H., & Mykkänen, L. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.223 · Cited by 286
Self-citationHigh density lipoprotein as a protective factor against coronary heart disease. The Framingham study
(1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90899-3 · Cited by 275
Lipoprotein predictors of the severity of coronary artery disease in men and women.
Reardon, M. F., Nestel, P. J., Craig, I. H., & Harper, R. W. (1985) · Circulation · doi:10.1161/01.cir.71.5.881 · Cited by 266
Management of Dyslipidemia in NIDDM
Garg, A., & Grundy, S. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.2.153 · Cited by 254
Buring, J. E., O'Connor, G. T., Goldhaber, S. Z., Rosner, B., Herbert, P. N., Blum, C. B., Breslow, J. L., & Hennekens, C. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.22 · Cited by 225
Ballantyne, F. C., Clark, R. S., Simpson, H. S., & Ballantyne, D. (1982) · Metabolism · doi:10.1016/0026-0495(82)90230-x · Cited by 209
Santen, R. J. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.130.6.833 · Cited by 166
Lipoproteins, cardiovascular disease, and death. The Framingham study
Gordon, T. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.141.9.1128 · Cited by 164
Penttilä, I., Voutilainen, E., Laitinen, P. H., & Juutilainen, P. (1981) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518109092057 · Cited by 157
Self-citationLaakso, M., Rönnemaa, T., Pyörälà, K., Kallio, V., Puukka, P. J., & Penttilä, I. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.449 · Cited by 153
Self-citationAssmann, G., & Schulte, H. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91084-h · Cited by 149
Relationship between lipoprotein levels and in vivo insulin action in normal young white men
Garg, A., Helderman, J. H., Koffler, M., Ayuso, R. M. A., Rosenstock, J., & Raskin, P. (1988) · Metabolism · doi:10.1016/0026-0495(88)90157-6 · Cited by 142
BRIONES, E. R., Mao, S. J. T., Palumbo, P. J., O’Fallon, W. M., CHENOWETH, W. L., & Kottke, B. A. (1984) · Metabolism · doi:10.1016/0026-0495(84)90160-4 · Cited by 122
Lipoprotein composition in diabetes mellitus
Howard, B. V., Savage, P. J., Bennion, L. J., & Bennett, P. H. (1978) · Atherosclerosis · doi:10.1016/0021-9150(78)90058-8 · Cited by 119
Abnormal Composition of High Density Lipoproteins in Non-insulin-dependent Diabetics
Biesbroeck, R., Albers, J. J., WAHL, P. W., et al. (1982) · Diabetes · doi:10.2337/diab.31.2.126 · Cited by 109
Hiramatsu, K., Bierman, E. L., & Chait, A. (1985) · Diabetes · doi:10.2337/diab.34.1.8 · Cited by 100
Laakso, M., & Barrett-Connor, E. L. (1989) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.9.5.665 · Cited by 97
Self-citationSerum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics
Laakso, M., Voutilainen, E., Sarlund, H., Aro, A., Pyörälä, K., & Penttilä, I. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90003-6 · Cited by 91
Self-citationRole of triglyceride-rich lipoproteins in progression of atherosclerosis.
Havel, R. J. (1990) · Circulation · doi:10.1161/01.cir.81.2.694 · Cited by 84
Plasma low density lipoprotein transport kinetics in noninsulin-dependent diabetes mellitus.
Kissebah, A. H., Alfarsi, S., Evans, D. J., & Adams, P. W. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110812 · Cited by 84
Treating high blood cholesterol in the older patient.
Gordon, D. J., & Rifkind, B. M. (1989) · American Journal of Cardiology · doi:10.1016/0002-9149(89)90116-1 · Cited by 67
Laakso, M., Voutilainen, E., Pyörälà, K., & Sarlund, H. (1985) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.5.6.653 · Cited by 63
Self-citationSarlund, H., Pyörälà, K., Penttilä, I., & Laakso, M. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.6.657 · Cited by 41
Self-citationLipid abnormalities in untreated maturity-onset diabetics and the effect of treatment
Simpson, R. W., Mann, J. I., Hockaday, T. D. R., Hockaday, J. M., Turner, R. C., & Jelfs, R. (1979) · Diabetologia · doi:10.1007/bf01225458 · Cited by 41
Blood lipids in treated diabetics
Perrett, A. D., Rowe, A. S., Shahmanesh, M., Allison, S. P., & Hartog, M. (1974) · Diabetologia · doi:10.1007/bf01219666 · Cited by 19
Tattersall, R. B. (1982) · Diabetes Care · doi:10.2337/diacare.5.6.646 · Cited by 18
Cited by
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., Laakso, M., & for The STOP-NIDDM Trial Research Group (2003) · JAMA · doi:10.1001/jama.290.4.486 · Cited by 1,624
Self-citationA review on coronary artery disease, its risk factors, and therapeutics
Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28350 · Cited by 1,141
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
Metadata
- Authors
- Laakso, M., Lehto, S., Penttilä, I., & Pyörälä, K.
- Venue
- Circulation
- Published
- 1993-10
- Volume
- 88
- Issue
- 4
- Pages
- 1421-1430
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2001979704
- Cited by
- 301
- References
- 40
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.